for long-acting injectable (LAI) technologies through a joint proposal with the University of Connecticut’s School of Pharmacy, Department of Pharmaceutical Sciences. This project aims ...
a novel composition of testosterone and anastrozole in a long-acting, slow-release subcutaneous implant. "Our new patent for T+Ai is a critical milestone as we advance through the ongoing RECAST DCIS ...